TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01331239

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LCI699
Description: Osilodrostat 1 mg and 5 mg capsules, was prepared by Novartis and supplied to the Investigator. The capsule formulation of osilodrostat was later changed to tablets and this change was implemented in the study with Protocol amendment 6. Osilodrostat was open labeled 1 mg, 5 mg, 10 mg and 20 mg tablets.
Study: NCT03849209

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Stylet slow-pull technique
Description: During endosonographic examination, the pancreatic mass was evaluated with color Doppler to avoid the involvement of vessels. The needle (20 Gauge, EchoTip ProCore 20G with ReCoil Stylet™, Cook Medical, Bloomington, IN, USA) was sharpened by withdrawing the stylet approximately 2 mm, and then was advanced into the lesion: 15 to-and-fro movements within the lesion were performed, with simultaneous minimal negative pressure provided by pulling the needle stylet slowly and continuously.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard suction technique
Description: During endosonographic examination, the pancreatic mass was evaluated with color Doppler to avoid the involvement of vessels. The needle (20 Gauge, EchoTip ProCore 20G with ReCoil Stylet™, Cook Medical, Bloomington, IN, USA) was sharpened by withdrawing the stylet approximately 2 mm, and then was advanced into the lesion: 15 to-and-fro movements within the lesion were performed using a 10-mL suction syringe.
Study: NCT02398214

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep hygiene
Description: LAST intervention (light, activity, and sleep training) consists of behavioral and educational strategies for increasing light exposure and physical activity, minimizing television viewing and reducing television viewing time to \< 2 hours per day, and engaging activities suitable to the child's motor development to minimize sleep disturbance.
Study: NCT03621696

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scale of Subjective Total Taste Acuity
Description: -Baseline, interim assessment (14-42 days post-surgery), day 1 of radiation, day 21 of radiation, day 36 of radiation, 6 weeks after completion of adjuvant therapy, 4 months after the completion of adjuvant therapy, 6 months after the completion of adjuvant therapy, 12 months after the completion of adjuvant therapy, and 24 months after completion of adjuvant therapy

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scale of Subjective Total Taste Acuity
Description: -Baseline, interim assessment (14-42 days post-surgery), day 1 of radiation, day 21 of radiation, day 36 of radiation, 6 weeks after completion of adjuvant therapy, 4 months after the completion of adjuvant therapy, 6 months after the completion of adjuvant therapy, 12 months after the completion of adjuvant therapy, and 24 months after completion of adjuvant therapy

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neck Dissection Impairment Index
Description: -Baseline, interim assessment (14-42 days post-surgery), day 1 of radiation, day 21 of radiation, day 36 of radiation, 6 weeks after completion of adjuvant therapy, 4 months after the completion of adjuvant therapy, 6 months after the completion of adjuvant therapy, 12 months after the completion of adjuvant therapy, and 24 months after completion of adjuvant therapy

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neck Dissection Impairment Index
Description: -Baseline, interim assessment (14-42 days post-surgery), day 1 of radiation, day 21 of radiation, day 36 of radiation, 6 weeks after completion of adjuvant therapy, 4 months after the completion of adjuvant therapy, 6 months after the completion of adjuvant therapy, 12 months after the completion of adjuvant therapy, and 24 months after completion of adjuvant therapy

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neck Dissection Impairment Index
Description: -Baseline, interim assessment (14-42 days post-surgery), day 1 of radiation, day 21 of radiation, day 36 of radiation, 6 weeks after completion of adjuvant therapy, 4 months after the completion of adjuvant therapy, 6 months after the completion of adjuvant therapy, 12 months after the completion of adjuvant therapy, and 24 months after completion of adjuvant therapy
Study: NCT03127995

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: HYPOFRACTIONATED
Description: 40 Gy/ 15 fractions / 3 weeks

Intervention type: RADIATION
Group type: OTHER
Intervention: NORMOFRACTIONATED
Description: 50 Gy/ 25 fractions / 5 weeks
Study: NCT03264235

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Keeogo
Description: Keeogo is a computer-controlled lower extremity motorized orthosis worn over the user's hips and legs. The controller box contains sensors that supply information about the kinematics and the kinetics of the user's lower extremities and includes software that recognizes the user's mobility intentions. The system is powered by a lithium-polymer battery. The leg brace assembly is mainly comprised of the actuator, the electronic boards, hip joint, and soft goods (cuffs, belts) for affixing the assembly to the user's legs. The waist belt comes in various sizes adapted to each wearer, and adds additional support of the device on the user.~Keeogo does not initiate any movement but waits for the user's lead. Once the user makes the first move, Keeogo assists according to the activity. The individual must be able to initiate and terminate steps.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Stair Training
Description: Individuals will participate in traditional stair training physical therapy for the same duration of time as Group 1.
Study: NCT02352610

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: LRTI

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: LRTI

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Biotenodesis Screw
Study: NCT00208312

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Regadenoson
Description: 0.4 mg, bolus intravenous injection

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adenosine
Description: 0.14 mg/kg/min for 6 minutes, intravenous infusion
Study: NCT02498561

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: nonsurgical periodontal therapy
Description: Scaling and root planning under local anaesthesia, in a total of four clinical visits Oral hygiene instructions including the modified Bass technique, regular toothpaste, and an appropriate interdental cleaning device with dental floss and interdental brush.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: oral hygiene instructions
Description: Oral hygiene instructions including the modified Bass technique, regular toothpaste, and an appropriate interdental cleaning device with dental floss and interdental brush

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: nonsurgical periodontal therapy
Description: Scaling and root planning under local anaesthesia, in a total of four clinical visits Oral hygiene instructions including the modified Bass technique, regular toothpaste, and an appropriate interdental cleaning device with dental floss and interdental brush.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: oral hygiene instructions
Description: Oral hygiene instructions including the modified Bass technique, regular toothpaste, and an appropriate interdental cleaning device with dental floss and interdental brush
Study: NCT01947244

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Doula Home Visiting
Description: The intervention is a doula enhancement to evidence-based home visiting services. Doulas provide home visits during pregnancy and for the first six weeks postpartum, which focus on prenatal health, preparation for childbirth, bonding with the baby, and breastfeeding education. Family support workers provide longer term home visiting services. These home visits focus on sensitive and responsive parenting, early infant care, bonding with the baby, child health and development, and maternal mental health.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Case management
Description: Mothers are offered two prenatal and two postpartum case management meetings to assess whether mothers' basic needs (housing, nutrition, health care, mental health) are being met and make appropriate referrals.
Study: NCT01688167

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MC and sexual risk reduction
Description: Four group counselling sessions focused on male circumcision and sexual risk reduction
Study: NCT02755844

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olaparib
Description: Olaparib tablet dose will be dose-escalated on 4 dose levels , guided by a continual reassessment method (CRM).~One cycle will be 28 days (4 weeks) in duration, except for cycle 1 which will be 6 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: metformin
Description: From week 3 metformin will be gradually escalated from 500 mg/day to 1500 mg/day with weekly 500 mg dose escalation levels
Study: NCT03818178

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Intralipid
Description: Half of the participants will receive either naso-duodenal infusion of intralipid or palm oil each participant will serve as their own saline control on the second study day.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Palm Oil Emulsion
Description: Half of the participants will receive either naso-duodenal infusion of intralipid or palm oil each participant will serve as their own saline control on the second study day.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: All participants will serve as their own controls with a saline infusion study day.
Study: NCT04213209

Intervention type: DRUG
Intervention: Brentuximab Vedotin (Genetical Recombination)
Description: Brentuximab Vedotin Intravenous Infusion
Study: NCT02755844

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: metronomic cyclophosphamide
Description: from week 2 Metronomic cyclophosphamide will be given continuously on an oral daily basis at 50 mg qd
Study: NCT01331863

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Airway and/or pulmonary Vessels Transplantation
Description: Use of a stent-supported aortic allograft to prevent pneumonectomy in lung cancer SURGERY
Study: NCT02906111

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: estriol
Description: Study Group, treated with estriol~Control Group, no drug treatment~Both groups will undergo vaginal surgery for prolapse

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: vaginal surgery
Description: Control Group
Study: NCT02052843

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Steps to Success

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Healthy Families
Study: NCT03769935

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: cis Platinum, etoposide, S1
Description: cisplatin 75 mg/m2, iv day1, Etoposide: 60 mg/m2 IV day 1-5, every 21 days for up to 4-6 cycles.~S1 25 mg/m2 oral, everyday until progression disease

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cis Platinum, etoposide, S1
Description: cisplatin 75 mg/m2, iv day1, Etoposide: 60 mg/m2 IV day 1-5, every 21 days for up to 4-6 cycles.~S1 25 mg/m2 oral, everyday until progression disease
Study: NCT00743600

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ultrasound of painful shoulder
Description: Patients who have a shoulder that is painful or has limited movement who were referred to Radiology will have an ultrasound exam of their shoulder.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ultrasound
Description: Healthy volunteers who do not have pain or limited movement will have an ultrasound exam of their shoulder.
Study: NCT02140359

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Network Interview
Description: Residents of a housing first permanent supporting housing program will be randomly assigned to this arm after screening and baseline assessments. They will meet roughly every two weeks with a case manager and answer questions about their social network, will be shown visual feedback about their networks, and will participate in a motivational interview conducted by the case managers. The questions and visualizations will be facilitated by an electronic tool for presenting screens with questions, capturing responses, processing and visualizing social network data.
Study: NCT01096849

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: levofloxacin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: plazomicin
Study: NCT04136470

Intervention type: BIOLOGICAL
Intervention: Collection of stool, blood (PBMC) and biopsy (FFPE)
Description: Patients receiving routine treatment (immunotherapy using anti-PD1 / anti-PDL1 and / or anti CTLA4 antibodies), financed by the Polish National Health Fund (NFZ).
Study: NCT01096849

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: plazomicin

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: placebo
Study: NCT02906111

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: vaginal surgery
Description: Control Group
Study: NCT03152448

Intervention type: BEHAVIORAL
Intervention: Prolaris
Description: Series of three questionnaires to capture treatment decisions based upon standard clinical-pathological information with the addition of Prolaris genomic testing result
Study: NCT01073969

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: wheat bran extract
Description: Comparison of control cereal (containing no added wheat bran extract)to two test cereals containing different amounts of added wheat bran extract
Study: NCT04005898

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Near-infrared fluorescence cholangiography
Description: Real-Time Fluorescence Imaging (VISERA ELITE II Imaging System). These device is used to identify anatomy, using infrared light that causes the indocianine green to fluoresce.
Study: NCT03331094

Intervention type: PROCEDURE
Intervention: Surgery with graft
Description: arthrodesis with autologous bone graft and using pedicular ilio-sacred EUROS ® screw

Intervention type: PROCEDURE
Intervention: surgery without graft
Description: arthrodesis without bone graft using pedicular ilio-sacred EUROS ® screw
Study: NCT01901731

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: transjugular coil embolisation of pelvic veins

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: endovenous treatment of leg varicose veins

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: endovenous treatment of leg varicose veins
Study: NCT01073969

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: wheat bran extract
Description: Comparison of control cereal (containing no added wheat bran extract)to two test cereals containing different amounts of added wheat bran extract

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: control wheat bran extract
Description: Comparison of control cereal (containing no added wheat bran extract) to two test cereals containing different amounts of added wheat bran extract
Study: NCT03182400

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Neurophysiological assessment
Description: Assessment of cerebral electrical activity Assessment of ocular exploration Neurovegetative assessments

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Neuropsychological assessment
Description: sub-tests, scales, surveys, reaction time measurement
Study: NCT02551198

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HAPREP®
Description: Arm1: HAPREP® (2L polyethylene glycol with ascorbic acid; PEG-Asc)~: : PEG-Asc(500mLx2 times q30min)\[PM 7-9, the day before colonoscopy\] + PEG-Asc(500mLx2 times q30min)\[AM 5-7, the day of colonoscopy\]

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SUCLEAR®
Description: Arm2: SUCLEAR® (oral sulfate solution; OSS): OSS(1b/177mL)\[PM 7-9, the day before colonoscopy\] + OSS(1b/177mL)\[AM 5-7, the day of colonoscopy\]
Study: NCT01658696

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: ChAd63 ME-TRAP and MVA ME-TRAP
Description: ChAd63 ME-TRAP: 5 x 10\^10vp MVA ME-TRAP: 2 x 10\^8 pfu heterologous prime-boost immunisation

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Rabies vaccine
Description: 2 x 2.5IU Verorab
Study: NCT01688089

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ODM103

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Entacapone

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levodopa/carbidopa
Study: NCT00951951

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Anterior Approach
Description: Anterior Minimal Invasive Surgery (AMIS)
Study: NCT01845532

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TPI
Description: Trigger point injection with 25G needle on the shoulder before surgery(0.5% procaine, 0.25\~0.5% lidocaine, 0.125% bupivacaine)
Study: NCT03169023

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ScaleDown
Description: -Participants receives behavioral prompts and daily feedback by text messaging with motivational instructions for specific dietary and behavior modifications

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced Usual Care Packets
Description: -From the American Cancer Society Website
Study: NCT00951951

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Posterior Approach
Study: NCT03418987

Intervention type: OTHER
Intervention: Medical File data analysis
Description: Analysis of the 2D/3D spine images (performed with the sterEOS software and the MATLAB software)
Study: NCT01823276

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Tyrosine-Containing Bar
Study: NCT03169023

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Usual Care Packets
Description: -From the American Cancer Society Website

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced Usual Care Packets
Description: -From the American Cancer Society Website

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 12-Item Short Form Health Survey
Description: -Measures functional health and well-being from the patient's perspective

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 12-Item Short Form Health Survey
Description: -Measures functional health and well-being from the patient's perspective

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 12-Item Short Form Health Survey
Description: -Measures functional health and well-being from the patient's perspective

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: International Physical Activity Questionnaire short form
Description: -7 item scale that measures a range of physical activity from vigorous to sedentary over the last 7 days

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: International Physical Activity Questionnaire short form
Description: -7 item scale that measures a range of physical activity from vigorous to sedentary over the last 7 days
Study: NCT01995097

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Scheduled Gradual Reduction Text Messages

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Support Text Messages

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Support Text Messages
Study: NCT02264314

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active Communication Education Program
Description: A behavioral intervention aimed to improve the adherence to the hearing aid in older adults with hearing loss
Study: NCT03169023

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: International Physical Activity Questionnaire short form
Description: -7 item scale that measures a range of physical activity from vigorous to sedentary over the last 7 days

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multidimensional Body Self Relations Questionnaire - Appearance Subscales
Description: -Gold-standard for the assessment of body image attitudes and contains 34 items

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Multidimensional Body Self Relations Questionnaire - Appearance Subscales
Description: -Gold-standard for the assessment of body image attitudes and contains 34 items
Study: NCT01823276

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Bar
Study: NCT02470091

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Denosumab
Description: Given SC
Study: NCT01845532

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: EMLA cream
Description: EMLA cream with occluding dressing on the shoulder before surgery(5% of eutectic mixture with 2.5% lidocaine and 2.5% prilocaine)
Study: NCT02470091

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmacological Study
Description: Correlative studies
Study: NCT00597116

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vinorelbine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vandetanib
Description: once daily oral dose
Study: NCT00543452

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Oxygen
Description: 4 liters of oxygen a minute

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Air from a placebo oxygen delivery
Description: 4 liters a minute of air from a placebo device
Study: NCT01753414

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy (SBRT)
Description: Daily fractions

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Surgery
Description: Radical resection
Study: NCT00478049

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gefitinib
Description: 250 mg oral tablet

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Docetaxel
Description: intravenous infusion
Study: NCT03122587

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Alternating Current Stimulation at 10 Hz
Description: Non-invasive, safe transcranial alternating current stimulation administered at 10 Hz to target alpha oscillatory activity
Study: NCT02264314

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Participants in this arm will not receive intervention during the study protocol time. After the completion of the protocol, they will receive the same intervention that the intervention group, meaning the ACE program intervention.
Study: NCT03114904

Intervention type: OTHER
Group type: OTHER
Intervention: Variation of Jasinski score between H0 (stop of sedatives) and H6
Description: To compare the effectiveness of a withdrawal management protocol with the usual management in cerebral patients (Subarachnoid haemorrhage (HSA), stroke and head trauma (CT))